Top Markets
#1 Islamic Coin Islamic Coin +151.60%
#2 Black Phoenix Black Phoenix +35.36%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.32%
#4 Akedo Akedo +16.20%
#5 Fake World Assets Fake World Assets +15.77%
#6 Palladium Network Palladium Network +15.41%
#7 HOME HOME +12.57%
#8 clBTC clBTC +11.81%
#9 DoubleZero DoubleZero +11.79%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +10.76%
Coin of the day
Islamic Coin Islamic Coin
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Ziccum AB (publ) Ziccum AB (publ)

Ziccum AB (publ)

ZICC
Kedudukan dalam Saham #39875
Ziccum AB (publ) specializes in creating stable dry powder formulations for... Ziccum AB (publ) specializes in creating stable dry powder formulations for biological pharmaceuticals. The company's core offering is LaminarPace, a proprietary spray drying technology they develop and commercialize. This innovative system enables the gentle, room-temperature drying of diverse substances, including chemicals, vaccines, biologics, and various other drug compounds. Established in 2017, Ziccum maintains its headquarters in Lund, Sweden.
Harga Saham
$0.02279104
Disegerakkan terakhir: 2025-02-04
Modal Pasaran
$315.99K
Perubahan (1 hari)
0.89%
Perubahan (1 tahun)
0.00%
Negara
SE
Perdagangan Ziccum AB (publ) (ZICC)

Kategori

Healthcare
Hasil untuk Ziccum AB (publ) (ZICC)
Hasil pada Sep 2024 TTM: $408.55K
Menurut laporan kewangan terkini daripada Ziccum AB (publ), hasil semasa syarikat (TTM) ialah $408.55K. Pada tahun 2022, syarikat memperoleh hasil sebanyak $1.63K peningkatan berbanding hasil pada tahun 2021 iaitu $552.48. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Ziccum AB (publ) dari 2017 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
2026 (TTM) $408.55K 10.00%
2023 $371.42K 22,681.73%
2022 $1.63K 195.09%
2021 $552.48 -8.68%
2020 $605.02 -99.14%
2019 $70.06K 175.72%
2018 $25.41K 0.00%
2017 0.00 0.00%
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 3,089,951.82%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 1,473,731.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B 2,474,718.79%
BE